MISP and cancer: This pathway has also been recognized as a significant regulator of ferroptotic cell death in cancers.[17, 19] Importantly, ferroptosis, particularly SLC7A11, a known inhibitor of ferroptosis induced by oxidative stress, was found to be upregulated in patients with high MISP expression (Figure S3A, Supporting Information).